Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Mitoq
2. Mito-q
3. Mitoquinone Methanesulfonate
4. Phosphonium, (10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl)triphenyl-, Methanesulfonate (1:1)
1. 845959-50-4
2. Mitoq
3. Mitoquinone Methanesulfonate
4. 6e01cg547t
5. Phosphonium, (10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl)triphenyl-, Methanesulfonate (1:1)
6. Dtxsid00233573
7. Refchem:159104
8. Dtxcid30156064
9. Unii-6e01cg547t
10. Mitoquinone (mesylate)
11. 10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl-triphenylphosphanium;methanesulfonate
12. Mitoq10 Mesylate
13. Mitoquinone Mesilate
14. Mitoubiquinone Mesylate
15. C38h47o7ps
16. Orb1992776
17. Schembl4423673
18. Chembl4074884
19. Mitoquinone (mitoq10) Mesylate
20. Chebi:234429
21. Hms6019o05
22. Ex-a1985
23. Mitoquinone Mesilate [who-dd]
24. Akos040733750
25. Cs-7565
26. Hy-100116a
27. Da-75568
28. Fm157162
29. G16037
30. Q15425822
31. (10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl)triphenylphosphonium Methanesulfonate
32. 10-(4,5-dimethoxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)decyl-triphenyl-phosphonium;methanesulfonate
| Molecular Weight | 678.8 g/mol |
|---|---|
| Molecular Formula | C38H47O7PS |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 16 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 118 |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 965 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
81
PharmaCompass offers a list of Mitoquinone mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mitoquinone mesylate manufacturer or Mitoquinone mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mitoquinone mesylate manufacturer or Mitoquinone mesylate supplier.
A Mitoquinone mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mitoquinone mesylate, including repackagers and relabelers. The FDA regulates Mitoquinone mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mitoquinone mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mitoquinone mesylate supplier is an individual or a company that provides Mitoquinone mesylate active pharmaceutical ingredient (API) or Mitoquinone mesylate finished formulations upon request. The Mitoquinone mesylate suppliers may include Mitoquinone mesylate API manufacturers, exporters, distributors and traders.
Mitoquinone mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mitoquinone mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mitoquinone mesylate GMP manufacturer or Mitoquinone mesylate GMP API supplier for your needs.
A Mitoquinone mesylate CoA (Certificate of Analysis) is a formal document that attests to Mitoquinone mesylate's compliance with Mitoquinone mesylate specifications and serves as a tool for batch-level quality control.
Mitoquinone mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Mitoquinone mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mitoquinone mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mitoquinone mesylate EP), Mitoquinone mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mitoquinone mesylate USP).
